辛伐他汀对高胆固醇大鼠创伤性脑损伤的神经保护作用
该研究在大鼠高胆固醇模型上探讨辛伐他汀对创伤性脑损伤(TBI)的神经保护作用。结果显示,辛伐他汀(4、10、20 mg/kg)可减轻TBI后运动缺陷,并减少神经元凋亡及炎症反应,尤其20 mg/kg剂量效果更明显,但血清胆固醇仍保持高水平。
要点
- 辛伐他汀减轻TBI后运动功能障碍,且不依赖于降胆固醇作用。
- 辛伐他汀减少缺血皮质神经元凋亡及TNFR1激活。
- 辛伐他汀抑制星形胶质细胞TNF-α表达,发挥抗神经炎症作用。
核心结论
- 辛伐他汀对高胆固醇大鼠TBI的神经保护作用可能与其抗神经炎症效应有关,而非降胆固醇效应。
研究设计与样本
- 5周龄雄性Sprague-Dawley大鼠高脂饮食8周诱导高胆固醇血症,分为假手术对照组、TBI对照组及TBI+辛伐他汀(4、10、20 mg/kg)组。
- 辛伐他汀在TBI后0、24、48小时腹腔注射,所有参数在TBI后第3天测量。
主要发现
- TBI显著增加血清胆固醇水平。
- 4、10、20 mg/kg辛伐他汀治疗在TBI后第3天显著减轻TBI诱导的运动缺陷。
- 辛伐他汀显著减轻TBI诱导的神经元TNFR1激活和凋亡,以及缺血皮质星形胶质细胞TNF-α表达,20 mg/kg作用尤其明显。
- 辛伐他汀治疗期间血清胆固醇仍保持高水平。
临床怎么用
- 对于合并高胆固醇的TBI患者,辛伐他汀的神经保护作用可能不依赖于降脂效果,需关注其抗炎机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High cholesterol has been correlated with a greater risk of cerebrovascular diseases. Whether pre-existing high cholesterol exacerbates traumatic brain injury (TBI), and whether treatment with the cholesterol-lowering agent simvastatin has neuroprotective effects, especially anti-neuroinflammatory effects, after TBI are not well investigated. METHODS: Five-week-old male Sprague-Dawley rats were fed a high-fat diet for 8 weeks to induce hypercholesterolemia. Anesthetized male Sprague-Dawley rats were divided into 5 groups, including the sham-operated control, TBI control, and TBI with simvastatin treatment (4 mg/kg, 10 mg/kg, or 20 mg/kg) groups. Simvastatin was intraperitoneally injected at 0, 24, and 48 hours after TBI. Motor function was measured using an inclined plane. Neuronal apoptosis (maker Neu-N, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling), tumor necrosis factor-α expression in microglia (marker OX42) and astrocytes (marker glial fibrillary acidic protein), and Tumor necrosis factor-alpha receptor (TNFR) 1 and TNFR2 expression in neurons in the ischemic cortex were investigated using an immunofluorescence assay. All of the parameters were measured on the third day after TBI. RESULTS: TBI significantly increased the serum levels of cholesterol. The TBI-induced motor deficit was significantly attenuated by 4, 10, and 20 mg/kg simvastatin therapy on the third day after TBI. TBI-induced neuronal TNFR1 activation and apoptosis, as well as tumor necrosis factor-α expression in astrocytes in the ischemic cortex, were significantly attenuated by simvastatin, particularly when 20 mg/kg was administered. Simultaneously, the serum cholesterol remained high despite simvastatin treatment. CONCLUSIONS: The neuroprotection effects of simvastatin on the pre-existing hypercholesterolemia during TBI in rats may be related to its anti-neuroinflammatory effects but not to its cholesterol-lowing effects.
引用
- Chong AJ, Lim SW, Lee YL, et al. The Neuroprotective Effects of Simvastatin on High Cholesterol Following Traumatic Brain Injury in Rats. World Neurosurg. 2019. PMID: 31518751. doi:10.1016/j.wneu.2019.08.250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。